What is it about?
痤瘡における12週間の他施設共同無作為化二重盲検平行群間比較試験の結果
Featured Image
Why is it important?
BPOが市販薬としても認可されていないため、全く使用していない人を対象にした試験であることが特徴。
Perspectives
Read the Original
This page is a summary of: Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication, The Journal of Dermatology, March 2017, Wiley,
DOI: 10.1111/1346-8138.13798.
You can read the full text:
Contributors
The following have contributed to this page